
News from Science-et-vie.com
Top Science-Et-vie.com News

FDA · WilmingtonTUESDAY, Sept. 2, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Leqembi Iqlik, a subcutaneous version of lecanemab, for weekly maintenance after the 18-month intravenous (IV) phase.See the Story
FDA Approves Subcutaneous Leqembi for Treatment of Early Alzheimer Disease
42% Center coverage: 19 sources